ELAREM™ Ultimate-FD PLUS

  • ELAREM™ Ultimate-FD PLUS 1
  • ELAREM™ Ultimate-FD PLUS 2
  • ELAREM™ Ultimate-FD PLUS 3
Product Description

ELAREM™ Ultimate-FD PLUS is a globally patented, gamma‑irradiated, GMP‑grade Human Platelet Lysate (HPL) produced in Europe.
The product undergoes gamma irradiation at a dose range of 38-55 kGy as a final manufacturing step. By conducting a viral clearance study, we demonstrated viral reduction for the tested viruses while preserving cell culture performance.

By ensuring an EU-based raw material supply chain, we provide a minimum traceability period of 30 years back to blood component.

Each batch is produced from large pools of platelet units. Consequently, this ensures batch-to-batch consistency and enables reproducible conditions.

ELAREM™ Ultimate-FD PLUS is manufactured, tested and released in compliance with the relevant GMP guidelines.

Read more Show less

PL BioScience

  • Country/Region:
    Germany
  • On CPHI since:
    2025
  • Certificates:
    2
  • Employees:
    1 - 24
Company types
Biopharmaceutical company
Primary activities
Laboratory, Analytical, Biotechnology Equipment
View company profile
Categories
more categories Show less
Specifications
  • Details
    ELAREM™ Ultimate-FD PLUS is a xeno-free cell culture supplement supporting the efficient and safe in vitro expansion of primary cells and cell lines. The product is especially suited to cell manufacturing applications requiring proven viral reduction, e.g. for potential use in clinical trials.
  • Selling Points
    Ethical Sourcing; Place of Origin; Product Features; Product Performance; Quality Service; Sustainability; ✅ Globally patented manufacturing process
    ✅ Suitable for sensitive cell manufacturing applications
    ✅ Manufactured, tested and released in compliance with the relevant GMP guidelines
    ✅ ISO 9001:2015 certified Quality Management System
  • Model
    Xeno-free cell culture supplement for cell manufacturing
  • Measured In
    litre
More specifications Fewer specifications
Sales Markets
Show more Show less

PL BioScience

  • Country/Region:
    Germany
  • On CPHI since:
    2025
  • Certificates:
    2
  • Employees:
    1 - 24
Company types
Biopharmaceutical company
Primary activities
Laboratory, Analytical, Biotechnology Equipment
View company profile

More Products from PL BioScience (1)

  • ELAREM™ Perform-FD PLUS

    Product ELAREM™ Perform-FD PLUS

    Due to a unique fibrinogen-depletion technique, ELAREM™ Perform-FD PLUS is a clot-free and anticoagulant-free Human Platelet Lysate enabling improved workflows. The product neither requires the addition of anticoagulants in cell culture nor during manufacturing. That makes ELAREM™ Perfo...

PL BioScience resources (1)

  • News World Novelty: Artificial HPL Solution

    PL BioScience develops worldwide first artificial Human Platelet Lysate (HPL) solution, and thus a key ingredient for the research & production of cell-based pharmaceuticals. The company has developed a proprietary method to transform lab-grown platelets into a powerful cell culture supplement.
    7 Aug 2025